Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.3%

2 terminated out of 15 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
P 2 (1)
P 3 (1)

Trial Status

Completed8
Terminated2
Unknown2
Recruiting1
Active Not Recruiting1
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07356843Recruiting

Palliative Care for People With HF

NCT06683053Phase 3Active Not RecruitingPrimary

Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department

NCT02983812Completed

Developing Enhanced Prediction Models

NCT02034045Not ApplicableCompleted

Expanding Paramedicine in the Community

NCT01960907Not ApplicableCompleted

Clinical Trials for Elderly Patients With Multiple Disease

NCT01044290Not ApplicableCompleted

Outlook Quality of Life Intervention Study

NCT00211874Not ApplicableCompletedPrimary

Improving Heart Failure Care in Minority Communities

NCT01831713TerminatedPrimary

Pulmonary Blood Flow Measurements in CHF Patients

NCT01744210WithdrawnPrimary

Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure

NCT00406575Phase 2TerminatedPrimary

Recombinant Human Relaxin for the Treatment of Decompensated CHF

NCT00528320UnknownPrimary

Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System

NCT01855022Not ApplicableCompletedPrimary

A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response

NCT01414439UnknownPrimary

Group Psychotherapy Among Congestive Heart Failure Patients

NCT00734045CompletedPrimary

Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

NCT00309764Not ApplicableCompletedPrimary

CHF Management Using Telemedicine

Showing all 15 trials

Research Network

Activity Timeline